Biochemical and Histological Evaluations of Articular Cartilages Preserved
in Cold Storage Solution Containing Green Tea Catechin, EGCG by 배정윤
380
Tissue Engineering and Regenerative Medicine, Vol. 6, No. 1~3,  pp 380-387 (2009)                                                                                                             
｜Original Paper｜
Biochemical and Histological Evaluations of Articular Cartilages Preserved 
in Cold Storage Solution Containing Green Tea Catechin, EGCG
Dong-Wook Han1,2, Jung Yoon Bae2 and Suong-Hyu Hyon2,*
1Dept of Nanomed Eng, College of Nanoscie Nanotech, Pusan Natl Univ, San 30 Jangjeon-dong, Geumjeong-gu, 
Busan 609-735, Korea, 2Dept Medical Simulation Eng, Res Center for Nano Medical Eng, Institute for Frontier Medical Sci, 
Kyoto Univ, 53 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan
(Received: Feb. 3rd, 2009; Accepted: Feb. 9th, 2009)
Abstract : Although epigallocatechin-3-O-gallate(EGCG), a major poly phenolic constituent of green tea, has var-
ious pharmacological and biological activities including anti-carcinogenic, anti-thrombotic and anti-inflammatory
effects, relatively a little is known about its beneficial effects on the non-frozen preservation of mammalian cells and
tissues. In this study, articular cartilages from human knee joint were pretreated with 1 mM EGCG for 1 d and then
preserved in serum-free RPMI 1640 media with 1% antibiotic-antimycotic solution at 4oC for 1, 2 and 4 wk. After
cold preservation, chondrocyte viability(CCK-8 assay), biochemical and immunohistochemical composition[gly-
cosaminoglycans and(type II)collagen], and biomechanical property(compressive elastic modulus) were assessed,
respectively. Chondrocyte viability of cartilages pretreated with EGCG was significantly well-maintained for at least
2 wk with high contents of glycosaminoglycan and total collagen. These beneficial effects of EGCG pretreatment
were more confirmed by histological and immunohistochemical observations showing well-preserved cartilaginous
structures and delayed denaturation of the extracellular matrices in preserved specimens. The compressive elastic
modulus(MPa) of cartilages pretreated with EGCG was well-maintained as much as that of fresh specimens without
any increase as the progress in the preservation period. Here were also found that fluorescein isothiocyanate-conju-
gated EGCG were widely distributed through the matrix and clearly observed at the chondrocytes in the lacunas.
Taking these results into consideration, it is suggested that EGCG may play an effective role in preserving articular
cartilages, which be exploited to craft strategies for the long-term preservation of osteochondral allografts under cold
storage conditions.




Articular cartilage injury is challenging to treat because of
limited intrinsic healing capacity.1,2 Although the natural
history of isolated cartilage lesions still is unknown,3 it
generally is thought that articular cartilage injury may
predispose the involved joint to accelerated degeneration.2,4
This problem is magnified by the relative frequency of cartilage
injuries.5,6 The unsuitability of total joint replacements for
young, active individuals has provided the stimulus to search
for alternative treatments in the field of biologic resurfacing of
joints. Numerous surgical treatments for chondral and
osteochondral lesions have been described, but each method
has certain limitations.7,8 On the other hand, tissue engineering
techniques and regenerative medicine have been explored as a
potential method to restore natural tissue and repairlesions.9,10
Nevertheless, no optimal method for the cryopreservation of
mammalian tissue or organ as well as tissue engineered medical
products and has been established.11 Also, current methods can
result in a substantial loss of function and lead to damage and
destruction of the cells and tissues.
The number of tissue or organ transplants has increased
substantially in recent years with the advances in the surgical
methods and the development of immunosuppressive
agents.12,13 Ideally, tissues should be transplanted immediately
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from the donor to the recipient. However, this is not always
possible, and the problem of tissue preservation is very
important for ensuring a successful transplantation. Therefore,
it is essential to develop storage solutions that can maintain the
viability and function of the tissues or organs for longer periods.
Usually, a dysfunction of the transplants occurs as the result of
free radicals due to ischemia, which triggers lipid peroxidation
of the cell membrane when the blood flow is restarted.14,15
Particularly, ischemic osteonecrosis can produce a permanent
residual deformity of the immature femoral head and
epiphyseal cartilage damage.16 A good storage solution should
prevent this peroxy lipid generation. Since this is related to cell
proliferation and division, longer term tissue preservation for
transplantation would become possible if cellular metabolism
can be controlled.17
From this point of view, our attention has been paid to (–)-
epigallocatechin-3-O-gallate(EGCG), the predominant
catechin from tea, since it has a wide range of pharmacological
activities, including antioxidant, anticancer, anti-proliferative,
anti-inflammatory and anti-thrombotic effects.18–20 Different
from these biological activities of EGCG, its cytopreservative
effects on mammalian cells and tissues were examined in order
to design a cell- or tissue-preserving medium/solution at
physiological temperature in our previous studies.18–20 The
present study provided support to a scenario in which EGCG
might play a key role in preserving articular cartilages by
maintaining chondrocyte viability and metabolism in cartilages
as well as matrix structure. Therefore, EGCG pretreatment can
be exploited to craft strategies for the long-term preservation of
osteochondral allografts under cold storage conditions.
2. Materials and Methods
 
2.1 Carti lage Specimen Collection and Cold
Preservation
Human articular cartilages were obtained from knee joints of
10 outpatients(male or female, 58 - 86 years old, 15 - 20 mm in
diameter and 2 - 2.5 mm in thickness) undergoing total knee
arthroplastic surgery at Marunouchi Hospital, Nagano,
Matsumoto-si, Japan. As shown in Fig 1, these specimens were
procured under sterile conditions from the donor and placed in
a storage solution[serum-free RPMI 1640 media(Sigma-
Aldrich Co, St Louis, MO) with 1% antibiotic-antimycotic
solution(including 10,000 units penicillin, 10 mg streptomycin
and 25 mg amphotericin B per mL, Sigma-Aldrich Co)] with 1
mM EGCG(Teavigo™, DSM Nutritional Products Ltd, Basel,
Figure 1. Experimental scheme of this study. Cartilage specimens were procured, pretreated without or with 1 mM EGCG in serum-free
RPMI 1640 media with 1% antibiotic-antimycotic solution, and kept at 4oC. The specimens were then delivered to the senior author(Prof
Hyon) within 1 day of procurement. Fresh cartilages were also delivered in the media with 10% FBS and 1% antibiotic-antimycotic
solution at room temperature. Immediately after receiving, the cartilage specimens were replaced with 20 mL of fresh media without
FBS and then stored at 4oC for 1, 2 and 4 wk without changing the storage solution. After preservation, biochemical, immunohistochem-
ical and biomechanical analyses were performed as described in Materials and Methods.
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Switzerland),21 and kept at 4oC (EGCG pretreatment). The
specimens were then delivered to the senior author(Prof Hyon)
within 1 d of procurement. Fresh cartilages(control) were
delivered in the media with 10% fetal bovine serum(FBS,
Sigma-Aldrich Co) and 1% antibiotic-antimycotic solution
immediately after procurement from the donor at room
temperature. Because of this necessary processing delay
between tissue procurement from the donor and its delivery, 1
day was set as the data point for the fresh specimen.
On receipt of the specimens, cartilage tissues were replaced
with 20 mL of fresh media without FBS and then stored at 4oC
for 1, 2 and 4oC wk without changing the storage solution. At
the end of each preservation period, biochemical, histological,
immunohistochemical and biomechanical analyses were
performed as described below. All procedures involving human
subjects received prior approval from Marunouchi Hospital,
Osaka City University Graduate School of Medicine and the
Institutional Review Board of Institute for Frontier Medical




The number of viable cells was quantified indirectly using a
highly water soluble tetrazolium salt[WST-8, 2-(2-methoxy-4-
nitrophenyl)-3-(4-nitro -phenyl)-5-(2,4-disulfophenyl)-2H-
tetrazolium, monosodium salt](Dojindo Lab, Kumamoto,
Japan), reduced to formazan dye by mitochondrial
dehydrogenase. The viability of chondrocytes was found to be
directly proportional to the metabolic reaction products
obtained in WST-8. According to the manufacturer’s
instructions, cartilage specimens following cold preservation
were incubated with WST-8 in the last 4 h of the incubation
period(24 h) at 37oC in the dark. Fresh cartilages were regarded
as their own controls, respectively. The absorbance was
determined at 450 nm in an ELISA reader(Spectra Max 340,
Molecular Device Co, Sunnyvale, CA).
 
2.3 Glycosaminoglycan(GAG) and Collagen Contents
GAG content was determined by using a dimethylmethylene
blue(DMMB) dye binding assay kit(Blyscan kit, Biocolor Ltd,
Newtownabbey, Northern Ireland, UK) according to the
manufacturer’s instructions. Chondroitin sulfate, provided with
the kit, was used as the GAG standard Briefly, 50 mg of
cartilage was homogenized and solubilized. A 100 mL aliquot
from each homogenate was added to 1 mL DMMB, in
duplicate, and mixed periodically at 25oC for 30 min. Solutions
were then centrifuged, and the supernatant discarded. The
remaining pellet was suspended in 1 mL of the provided
dissociation reagent, and absorbance measurements were taken
at 656 nm. The determined GAG contents were normalized
with the chondrocyte viability.
Total cartilage collagen levels were determined by using a
Sircol collagen dye binding assay kit(Biocolor Ltd) according
to the manufacturer’s instructions. Briefly, 50 mg of cartilage
was homogenized, and total acid pepsin-soluble collagens were
extracted overnight using 5 mg/mL pepsin in 500 mL of 0.5 M
acetic acid. One mL of Sircol dye reagent was added to 100 mL
of each homogenate, in duplicate, and incubated at 25oC for 30
min. After centrifugation, the pellet was suspended in 1 mL of
alkali reagent, and absorbance was read at 540 nm. The
determined collagen contents were normalized with the
chondrocyte viability.
 
2.4 Histological and Immunohistochemical Analyses
At the completion of the predetermined preservation, each
cartilage specimen was rinsed with phosphate-buffered
saline(PBS, pH 7.4) and immediately fixed with 2%
glutaraldehyde, 2% paraformaldehyde and 0.2% CaCl2,
followed by embedding in paraffin. The tissue blocks were
sectioned by a 5mm thickness, stained with hematoxylin and
eosin(H&E, for general evaluation) and Safranin-O/fast
green(for GAG content and distribution), and immunostained
with rabbit monoclonal antibody against type II collagen. The
prepared sections were examined using an optical/fluorescence
microscope(Biozero-8000, Keyence, Osaka, Japan).
Additionally, the cartilage specimens were pretreated with 1
mM fluorescein isothiocyanate(FITC, Sigma-Aldrich Co)-
conjugated EGCG(FITC-EGCG) in a storage solution for 1 d
and preserved for 2 wk at 4oC in order to determine whether
EGCG penetrated into the matrix of cartilages with further
incorporation into the cytosol of cells in lacunae or not. The
tissue sections were prepared as mentioned above and then
observed under a fluorescence microscope(Keyence).
 
2.5 Biomechanical Analysis
At each data point, cartilage specimens were removed from
the storage solution and placed immediately in a -80 freezer
until biomechanical testing could be done. At the time of
testing, each specimen was thawed at room temperature(25oC)
in PBS plus proteinase inhibitors. A cartilage compression disk
with an intact articular surface measuring 10 mm in diameter×
1 mm in thickness was made from each specimen. To determine
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the compressive elastic modulus, this cartilage disk was then
subjected to dynamic visco-elastic compression(Rheogel E-
4000, UBM Co Ltd, Japan) with 0.5% strain. All data were
collected at a frequency of 10Hz.
 2.6 Statistics
All variables were tested in three independent storages for
each experiment, and each experiment was repeated
twice(n=6).  Quantitat ive data  were expressed as
mean±standard deviation(SD). Statistical comparisons were
carried out with a one-way analysis of variance(ANOVA, SAS
Institute Inc, Cary, NC, USA), which was followed by the
Bonferroni test for the multiple comparisons. A value of p<0.05
was considered statistically significant.
3. Results
 
3.1 Protective Effects of EGCG on Chondrocyte
Viability of Cartilages
Preserving the cartilage specimens without EGCG
pretreatment resulted in a significant(p < 0.05) time-dependent
reduction in the chondrocyte viability(Fig 2). Their viability
was reduced to approximately 39% already after 1 wk and 30%
after 2 wk. When the specimens were pretreated with 1 mM
EGCG, their viability loss was only 31% even after 2 wk,
suggesting that EGCG pretreatment prevents there duction of
cellular viability. This compound seemed to actively penetrate
into the cartilaginous layer, leading to the protection of cell
viability. Although this decrease in the viability was accelerated
with the progress in the incubation time, there was a
significant(p < 0.05) difference between cartilages pretreated
without and with EGCG after 2 wk. However, after 4 wk, the
protective activity was relatively less exerted by EGCG, and the
viability was reduced to about 44%.
 
3.2 Protective Effects of EGCG on Contents of GAG
and Collagen in Cartilages
GAG and collagen contents of the cartilages correlated well
with their viability as shown in Fig 3. After 1 wk of preservation
without EGCG pretreatment, GAG content was about 67%,
which was significantly(p < 0.05) lower than that of the fresh
specimen(Fig 3A). As the progress in the preservation time, this
declined to 57% at 2 wk and then decreased dramatically to
39% at 4 wk. However, pretreatment with EGCG improved the
chondrocyte metabolism in cartilages. After 2 wk of
preservation with EGCG pretreatment, GAG content was
measured as approximately 77%, which was appreciably
higher than that of preservation without EGCG pretreatment.
After 4 wk of storage with EGCG, the content significantly(p <
0.05) decreased to 58% compared with the fresh. However, this
was still noticeably higher than that of storage without EGCG
for the same duration. Collagen contents showed a similar
pattern to that of GAG. Although there was no significant
difference in the contents between preservation without and
Figure 2. Chondrocyte viability in cartilages pretreated without or
with EGCG. Cell viability was measured with a WST-8 assay as
described in Materials and Methods. The results are reported as
mean±SD(n=6) and analyzed by the Bonferroni test(*p<0.05 vs
fresh controland #p<0.05 vs with EGCG at each time point).
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with EGCG pretreatment, the values in EGCG-pretreated
cartilages were remarkably higher than those in non-treated
specimens(Fig 3B). In addition, it was revealed that the
extracellular matrix(ECM) components of the cartilages did not
change appreciably during the study period(Fig 3C and 3D).
After storage without and with EGCG pretreatment, there
essentially were no fluctuation in the normalized contents(per
cell viability) of GAG and total collagen.
 
3.3 Protective Effect of EGCG on Matrix Structure of
Cartilages
Routine histological and immunohistochemical
examinations were performed on cartilage specimens
preserved without or with EGCG(Fig 4). Through the H & E
staining, it was difficult to differentiate between cartilages
preserved without and with EGCG(Fig 4A). However, there
was a numerical trend favoring EGCG-pretreated specimens
preserved for 2 wk. EGCG-pretreated specimens stained
positively with Safranin-O showing abundant presence of
GAG, which was comparable to that of fresh ones(Fig 4B). In
contrast, non-treatment resulted in an appreciable decrease in
the positivity for Safranin-O. The peripheral region of each
cartilage had a higher cell density and stained more intensely
for GAG in comparison to the central region. The cells in the
lacunas of fresh and EGCG-pretreated cartilages were well-
maintained with an original chondrocytic phenotype compared
with those of non-treated specimens. Immunohistochemical
examination using type II collagen antibody showed the
presence of this macromolecule in the cartilages pretreated with
EGCG, and again, the cell density and staining intensity were
greatest in the periphery of the specimens(Fig 4C). In each of
the specimens examined, type II collagen primarily was found
intracellularly. Comparison of cartilage tissues that stained
positive for both GAG and type II collagen within the same
specimen revealed that Safranin-O positive tissues had the
usual association with type II collagen typically seen in normal
or fresh articular cartilage.
 
3.4 Penetration and Incorporation of FITC-EGCG
into Cartilages
The penetration of EGCG into the matrices of cartilages and
its incorporation into the cytosol of cells were confirmed after
Figure 3. ECM composition of cartilages pretreated without or
with EGCG. GAG contents(A) and total cartilage collagen lev-
els(B) were determined by using a DMMB dye binding assay kit
and a Sircol collagen dye binding assay kit, respectively, as
described in Materials and Methods. Additionally, the normal-
ized contents(per cell viability) of GAG(C) and total collagen(D)
were plotted. The results are reported as mean±SD(n=6) and ana-
lyzed by the Bonferroni test(*p<0.05 vs. fresh control).
Figure 4. ECM structure of cartilages pretreated without or with
EGCG. Cartilage specimens were stained with either H&E(A) or
Safranin-O/fast green(B, for GAG content and distribution), and
immunostained with rabbit monoclonal antibody against type II
collagen(C). The photographs shown in this figure are represen-
tative of 6 independent experiments, showing similar results.
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2 wk of storage with FITC-EGCG treatment(Fig 5). FITC-
EGCG was located at any places through the matrix and clearly
observed at the cells in the lacunas of the cartilages treated with
FITC-EGCG. These results imply that although the cellular
sensitivity and response to EGCG would be different from
those of FITC-EGCG, EGCG could easily bind to the matrices
as well as the cells and be incorporated into the cytosol, which
would lead to protection of the cells from oxidative stress
generated during cold preservation period.
 
3.5 Protective Effect of EGCG on Biomechanical
Property of Cartilages
Biomechanical testing evaluated the function of the existing
cartilage matrix, and opposite to the contents of GAG and
collagen, the strength of non-treated cartilages appreciably
increased with time(Fig 6). The value significantly(p<0.05)
increased after 2 wk, which was about 2.0 times higher than that
of the fresh specimens. However, no significant changes in the
compressive elastic modulus, if any, slightly increased, were
detected in EGCG-pretreated cartilages.
4. Discussion
 
It was found that chondrocyte viability of EGCG-pretreated
cartilages was significantly well-maintained for at least 2 wk
with high contents of GAG and total collagen, histological and
immunohistochemical appearance of well-preserved
cartilaginous structures, delayed denaturation of ECM, and no
alterations of compressive elastic modulus. These results can be
attributed to the fact that EGCG might actively penetrate into
the cartilaginous layer and protect the chondrocyte viability and
metabolism in cartilages as well as the matrix structure.
Histologically, metachromatic staining of cartilage matrix
preserved without EGCG for 2 wk was lost mainly from
perichodrocyte area, suggesting that chondrocytes which lost
their viability digested matrix by themselves. It was found that
Figure 5. Penetration of EGCG into cartilaginous matrices and its intracellular incorporation. Cartilage specimens were pretreated with
400 mg/mL FITC-EGCG, preserved for 2 wk and then observed under a fluorescence microscope. The micrographs shown in this figure
are representative of 6 independent experiments, showing similar results.
Figure 6. Biomechanical property of cartilages pretreated without
or with EGCG. Compressive elastic modulus was determined by
dynamic visco-elastic compression as described in Materials and
Methods. The results are reported as mean±SD(n=6) and ana-
lyzed by the Bonferroni test(*p<0.05 vs. fresh control and
#p<0.05 vs. with EGCG at each time point).
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EGCG penetrated into the matrices of cartilages and was
incorporated into the cytosol of cells, enabling cartilaginous
structures of preserved cartilages to be well-preserved and
allowing denaturation of ECM to be delayed. Because the
viability of chondrocytes in cartilages was kept high at least 2
wk, this procedure may effective not only in preserving the
allogeneic osteochondral graft but also chondrocyte
transplantation, such as autologous chondrocyte implantation
and allogeneic chondrocyte transplantation. In case of
chondrocyte transplantation, we have to harvest cartilage and
carry it to cell processing center, which takes a few hours to a
couple of days. Because maintaining cell viability is highly
important in cell transplantation, this procedure may be useful
in carrying cartilage.
A point to be solved is that there was a time-dependent
decline in the metabolic activity(ECM contents) of the cartilage
during cold preservation. These findings correlated highly with
chondrocyte viability. In contrast, a recent study showed that
storage of human osteochondral allografts in serum-free culture
media at 4oC provided significantly better preservation of the
metabolic activity and biomechanical property of the tissues
with no significant detrimental alterations after 2 wk of
storage.22 When normalized with the chondrocyte viability of
the tissue, however, the contents of GAG and total collagen in
the present study remained stable throughout the 4 wk study
period. There are a number of explanations for these
inconsistencies, including the determination methods of cell
viability and ECM contents as well as the measurement method
of compressive elastic modulus. We have to further investigate
the limit of storage time using in vivo experiment.
In the present study, the hypothesis was testified that EGCG
pretreatment enables to extend storage duration for the cold
preservation of human articular cartilages from knee joints. To
our knowledge, little has been published on the beneficial
effects of EGCG on the prolonged cold storage of human
osteochondral grafts and the mechanism at cellular level. The
penetration of EGCG into the matrices of cartilages and its
cellular uptake into chondrocytes in the lacunas were clearly
observed. It is not dangerous to conclude that these phenomena
could be related to the intrinsic characteristics of polyphenolic
compound, EGCG. It has already been known that this
compound, due to its amphipathic properties, easily binds to
ECM, lipid membranes and any types of intracellular
proteins.23–25 Therefore, it seems that this compound enables to
be internalized into cell cytosol and further to be translocated
into nucleus, which leads to modulating the exogenous signals
directed to genes required for the survival and apoptosis of
cells. Although exact mechanism of the internalization of
EGCG into cells had not been elucidated yet, some evidence
was reported showing that EGCG was bound to the membrane
as well as incorporated into the cytosol and the nucleus of
cancer cell lines, such as PC-9 and HT-29 cells.26,27
Consistently, recent study has demonstrated that expression of
the metastasis-associated 67 kDa laminin receptor might confer
EGCG responsiveness to cancer cells at physiologically
relevant concentrations, suggesting that the gallate moiety of
EGCG may be critical for receptor binding and subsequent
activity.28,29 Moreover, the observation that nucleic acids
extracted from catechin-treated cells were colored implied that
because both galloyl and catechol groups of EGCG were
essential for DNA binding, both groups seemed to hold strands
of DNA via their branching structure.30
Taking these results into consideration, it is concluded that
EGCG plays effective roles in preserving articular cartilages by
penetrating into the matrices of cartilages and incorporating
into the cytosol of chondrocytes, which is regarded as a feasible
action mechanism of EGCG. Thus, it is suggested that these
results can be exploited to craft strategies for the long-term
preservation of osteochondral allografts under cold storage
conditions.
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